Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib

Subjects

Subjects :

0301 basic medicine
Niacinamide
Cancer Research
Allosteric regulation
Fusion Proteins, bcr-abl
Drug resistance
Article
03 medical and health sciences
Bcr abl1
Myelogenous
0302 clinical medicine
Cell Line, Tumor
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
medicine
Humans
Protein Kinase Inhibitors
Cell Proliferation
Chemistry
Hematology
medicine.disease
Fusion protein
Leukemia
030104 developmental biology
Oncology
Cell culture
Drug Resistance, Neoplasm
030220 oncology & carcinogenesis
Cancer research
Pyrazoles
K562 Cells
K562 cells

Details

ISSN :

14765551

Volume :

31

Issue :

12

Database :

OpenAIRE

Journal :

Leukemia

Accession number :

edsair.doi.dedup.....c759cd5e8d6d2dbf4e2143429940de8c